Title:
EZH2の阻害剤
Document Type and Number:
Japanese Patent JP6704040
Kind Code:
B2
Abstract:
The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.
More Like This:
JP7057119 | Organic electroluminescence element |
WO/2021/202480 | COMPOUNDS TARGETING PRMT5 |
JP2007509123 | Thieno-pyridinone derivative as a kinase inhibitor |
Inventors:
Dominguez, Esteban
Guo, Deki
Madder, Marie Margaret
Nguyen, Anne-Kuan Hanner
Del Prado, Miriam Philadelphia
Richett, Michael Enrico
Rodriguez, Michael John
Yp, Yvonne Emai
Yu, Quo-Long
Guo, Deki
Madder, Marie Margaret
Nguyen, Anne-Kuan Hanner
Del Prado, Miriam Philadelphia
Richett, Michael Enrico
Rodriguez, Michael John
Yp, Yvonne Emai
Yu, Quo-Long
Application Number:
JP2018510778A
Publication Date:
June 03, 2020
Filing Date:
August 22, 2016
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07D495/04; A61K31/4412; A61K31/55; A61K33/243; A61P1/00; A61P11/00; A61P15/00; A61P19/00; A61P35/00; A61P43/00
Domestic Patent References:
JP2004504342A | ||||
JP2004524277A | ||||
JP2005508322A | ||||
JP2015511603A | ||||
JP2015518053A |
Foreign References:
WO2014177982A1 | ||||
WO2014097041A1 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki